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Despite their large size, protozoan parasites are particularly adept at avoiding the unwanted attention of their hosts.
This remarkable ability highlights the need for equally clever strategies to prevent and treat infection. With parasitic
diseases such asmalaria and sleeping sickness affecting manymillions in the developing world, recent research in
genetics and cell biology provides us with a chance to fight back. In this issue’s Select, the spotlight falls on three
parasitic pathogens: Plasmodium, Trypanosoma, and Leishmania.A trypanosome probes the cell surface.Sneaking In with the Repair Work
Although many pathogens take advantage of membrane trafficking pathways to
enter host cells, a recent paper by Norma Andrews and colleagues shows that
Trypanosoma cruzi performs the taskwith an unusual degree of duplicity. The parasite
damages the plasma membrane, but this damage does not directly promote parasite
entry into the cytoplasm; blocking a calcium-sensitive plasma membrane repair
mechanism actually reduces rather than enhances infection.
Why is repair required for entry? By causing damage, the parasite triggers themobi-
lization of lysosomes that fuse with the plasma membrane and deliver the enzyme
acid sphingomyelinase (ASM) to the cell surface. Fernandes et al. show that cells lack-
ing ASM are resistant to infection, and treating the cells with exogenous, extracellularenzyme is sufficient to promote trypanosome entry. Enrichment of ASM in the outer leaflet of the plasma membrane stimu-
lates endocytosis, giving the parasite the chance that it needs to hitch a ride into the cell. The exploitation of the membrane
repair machinery by Trypanosoma may explain why these parasites tend to infect smooth muscle and cardiomyocytes,
tissues in which the repair mechanism is particularly active.
Fernandes, M.C., et al. (2011). J. Exp. Med. 208, 909–921.Malaria imposes a heavy
burden on healthcare in Togo,
West Africa. Photograph by
Shannon Heuklom.Malaria: A Rapidly Evolving Story
A battery of different drugs is available to prevent and treat malaria. However, the limited prog-
ress that has been made in controlling this deadly infection is at risk from the emergence of
resistant strains of the malaria parasite Plasmodium falciparum. Thankfully, high-throughput
genomics is providing increasingly powerful tools with which to keep track of the shifting
genetic landscape of Plasmodium and identify specific mutations that confer drug resistance.
A recent paper by Pardis Sabeti, DyannWirth, and colleagues illustrates this strategy and iden-
tifies a new antimalarial resistance gene.
By sequencing nine geographically diverse strains of Plasmodium, they identify new single-
nucleotide polymorphisms (SNPs) that are used to construct high-density genotyping arrays
covering 17,582 markers. Using these arrays, they characterize 57 different Plasmodium
strains and identify loci under different forms of selection. They also analyze the drug resistance
profile of these strains and discover loci that are associated with resistance to 13 different
drugs by performing genome-wide association studies (GWAS). Performing GWASwith a rela-
tively small number of heterogeneous samples increases the risk of identifying false positives.
However, at least one of the identified loci is a functional resistance gene, as its overexpression
leads to increased resistance to several different antimalarial compounds. Monitoring the
spread of such resistance loci will be an important weapon in effectively combating malaria, but the future is potentially
even brighter. With the cost of whole-genome sequencing plummeting, it will soon be possible to directly sequence every
nucleotide from clinical isolates of Plasmodium, allowing us to directly associate SNPs with highly specific clinical pheno-
types. Such studies should provide us with a wealth of new targets for drug and vaccine design in the future.
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Anopheles mosquito larva expressing
GFP. Photograph by Sinclair Stammers.Total Wipeout
Designing new treatments and improving the targeting of current therapies are vital
tools in the fight against malaria and other parasitic diseases. However, preventing
the spread of infection is a potentially more effective option, so the insect hosts
that carry disease between humans are also an important target. The aim is to identify
a safe and effective means of either eradicating or in some way disabling entire pop-
ulations of disease vectors such as Anopheles gambiae, the mosquito that hosts the
Plasmodium parasite that is responsible for malaria. Introducing genetically modified
mosquitoes into the wild has long been proposed as one way to achieve this goal.
However, for this approach to work, the modification must avoid becoming diluted
in the population and eventually disappearing in the wild.
Now, Andrea Crisanti and coworkers propose an elegant solution to the problem.
They take advantage of a class of selfish genetic elements called homing endonucle-
ases. These elements are capable of copying themselves from one chromosome to the equivalent location on its homologous
pair. They do so by cutting only at a specific genomic location (their target sequences are rare); the cell’s DNA repair
machinery then completes the copying process by using the homing endonuclease sequence on the homologous chromo-
some as a repair template. This ‘‘homing’’ mechanism allows them to spread rapidly through populations. Homing endonu-
cleases are only thought to exist naturally in single-celled organisms, and it remained unclear whether they would operate
successfully in the germline of a metazoan. Crisanti and his team now demonstrate that, despite their absence from insect
genomes, homing endonucleases can be used to transmit themselves through caged populations ofmosquitoeswith remark-
able efficiency. By introducing a homing endonuclease into the genome of a ‘‘donor’’ population, and an endonuclease
cleavage site within a GFP marker gene into a ‘‘target’’ population, they show that the homing endonuclease rapidly spreads
over multiple generations and inactivates the GFP marker. Their work overcomes a significant barrier preventing the use of
population-based genetic modification to reduce the spread of malaria. The next step will be to engineer a homing endonu-
clease to target an endogenous Anopheles sequence, and this work is already well underway.
Windbichler, N., et al. (2011). Nature 473, 212–215.4E-BP knockout mice exhibit resistance to cutaneous Leish-
maniasis.Silencing the Alarm System
Leishmaniasis currently affects up to 12 million people worldwide
and can be lethal in its most severe form. Leishmania parasites
are transmitted to humans by female sand flies during a blood
meal and are phagocytosed by macrophages in the bloodstream.
Nahum Sonenberg and coworkers now report that Leishmania
successfully avoids triggering an immune response by taking
drastic measures to silence the host cell.
They show that a metalloprotease in the parasite membrane
cleaves and inactivates mTOR. This key kinase promotes protein
translation by phosphorylating and inactivating the translational
repressor 4E-BP. Inhibiting mTOR signaling therefore allows the
parasite to suppress the translation of a potentially large number
of different genes. Tellingly, mice lacking 4E-BP are less susceptible to infection by Leishmania, suggesting that translational
silencing is an importantdiseasemechanism.Theknockoutmicealsooffer an important clueas tohowsilencingmightpromote
infection: they express greater quantities of type I interferons. These results suggest that Leishmania evades immunedetection
at least in part by inhibiting the interferon response.
Jaramillo, M., et al. (2011). Cell Host Microbe 9, 331–341.
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